Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:09 pm Unchanged | 2025-11-06 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 9.000% | 0 (Unchanged) | Filing History |
| 2026-02-13 5:08 pm Purchase | 2024-12-31 | 13G | Q32 Bio Inc. QTTB | PFIZER INC PFE | 277,777 2.300% | 277,777 (New Position) | Filing History |
| 2026-02-13 5:07 pm Sale | 2025-12-31 | 13G | NextCure, Inc. NXTC | PFIZER INC PFE | 157,646 3.000% | -302,731 (-65.76%) | Filing History |
| 2025-03-24 6:55 pm Sale | 2025-03-21 | 13D | Haleon plc HLN | PFIZER INC PFE | 0 0.000% | -661,709,764 (Position Closed) | Filing History |
| 2025-03-20 12:20 pm Unchanged | 2025-03-18 | 13D | Haleon plc HLN | PFIZER INC PFE | 661,709,764 7.300% | 0 (Unchanged) | Filing History |
| 2025-02-27 10:39 am Unchanged | 2025-02-25 | 13D | Haleon plc HLN | PFIZER INC PFE | 661,709,764 7.300% | 0 (Unchanged) | Filing History |
| 2025-02-12 2:51 pm Unchanged | 2024-12-31 | 13G | Zura Bio Limited ZURA | PFIZER INC PFE | 2,970,022 4.600% | 0 (Unchanged) | Filing History |
| 2025-02-12 2:48 pm Unchanged | 2024-12-31 | 13G | Cardiff Oncology, Inc. CRDF | PFIZER INC PFE | 2,411,575 3.600% | 0 (Unchanged) | Filing History |
| 2025-01-21 6:26 pm Sale | 2025-01-17 | 13D | Haleon plc HLN | PFIZER INC PFE | 661,709,764 7.300% | -700,000,000 (-51.41%) | Filing History |
| 2025-01-16 4:34 pm Unchanged | 2025-01-14 | 13D | Haleon plc HLN | PFIZER INC PFE | 1,361,709,764 15.000% | 0 (Unchanged) | Filing History |
| 2024-10-03 6:59 pm Sale | 2024-10-03 | 13D | Haleon plc HLN | PFIZER INC PFE | 1,361,709,764 15.000% | -700,526,315 (-33.97%) | Filing History |
| 2024-10-01 7:38 pm Unchanged | 2024-09-30 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | Filing History |
| 2024-08-05 6:12 pm Sale | 2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 0 0.000% | -27,349,211 (Position Closed) | Filing History |
| 2024-07-29 4:33 pm Unchanged | 2024-07-29 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | 0 (Unchanged) | Filing History |
| 2024-03-22 09:05 am Sale | 2024-03-21 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,062,236,079 22.600% | -892,827,547 (-30.21%) | Filing History |
| 2024-03-19 8:48 pm Unchanged | 2024-03-19 | 13D | Haleon plc HLN | PFIZER INC PFE | 2,955,063,626 32.000% | 0 (Unchanged) | Filing History |
| 2024-03-15 07:45 am Unchanged | 2024-01-29 | 13G | Tourmaline Bio, Inc. TRML | PFIZER INC PFE | 1,272,214 4.960% | 0 (Unchanged) | Filing History |
| 2024-02-14 3:48 pm Purchase | 2023-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR | PFIZER INC PFE | 2,243,850 3.470% | 2,243,850 (New Position) | Filing History |
| 2024-02-14 3:31 pm Purchase | 2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN | PFIZER INC PFE | 389,429 0.950% | 389,429 (New Position) | Filing History |
| 2024-02-14 2:29 pm Purchase | 2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | PFIZER INC PFE | 1,362,499 4.580% | 1,362,499 (New Position) | Filing History |